Cocaine, is it really there? Differing sensitivities of immunoassay drug screen and mass spectrometry

Hana Vakili, Khushbu Patel, Patricia M. Jones

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

A case of a 23-month-old girl who presented with an upper respiratory tract infection and seizure activity potentially due to cocaine exposure has been described. Two urine samples were drawn 1.5hours apart. The initial sample was positive for the benzoylecgonine using an immunoassay screen and mass spectrometry-based tests. However, the sample drawn after about 1.5hours after the first one was negative for cocaine metabolite by immunoassay. The finding was consistent with the fact that the child had been exposed to cocaine with the low levels of metabolite suggesting either a low dose exposure or exposure that may have occurred a few days prior to her presentation. This case highlights the preanalytical variables such as timing of urine collection and its impact on urine drug testing.

Original languageEnglish (US)
Title of host publicationToxicology Cases for the Clinical and Forensic Laboratory
PublisherElsevier
Pages493-496
Number of pages4
ISBN (Electronic)9780128158463
ISBN (Print)9780128163733
DOIs
StatePublished - Jan 1 2020

Keywords

  • Cocaine
  • LC/Q-TOF mass spectrometry
  • benzoylecognine
  • immunoassay drug screening

ASJC Scopus subject areas

  • General Medicine

Fingerprint

Dive into the research topics of 'Cocaine, is it really there? Differing sensitivities of immunoassay drug screen and mass spectrometry'. Together they form a unique fingerprint.

Cite this